ReviewCureus2026
Beyond Melanin: A Literature Review of Photoprotection Mechanisms and Gaps in Skin of Color.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is a critical need for tailored photoprotection in skin of color (SOC) populations. SOC has higher eumelanin-to-phenomelanin ratios, more mature melanosomes, and enhanced DNA repair capacity compared with lighter skin. The quantity and distribution of melanin in darker skin provide natural photoprotection. This leads to a misconception that SOC populations are inherently protected from all photodamage and serves as a barrier to proper photoprotection for these populations. Although the skin cancer incidence is lower in dark skin, mortality is higher, perhaps as a result of late diagnosis or misdiagnosis. These populations are still susceptible to skin damage from ultraviolet (UV) radiation, resulting in exacerbation of various dermatologic conditions, including pigmentation disorders, photodermatoses, and skin cancer. This review aims to comprehensively examine the photoprotection needs for SOC populations, addressing gaps between physiological characteristics and clinical outcomes, evaluating current photoprotection practices, examining educational implications, and considering future directions for photoprotection for SOC. A literature search was performed using PubMed and Google Scholar. The search was conducted from database inception through July 15, 2026. Articles were included if they addressed photoprotection, photodamage, photoaging, pigmentary disorders, photodermatoses, or skin cancer in SOC populations. Visible light (VL) and long-wave UVA1 are significant contributors to pigmentary alteration in SOC. The major drivers of pigmentation in SOC and photodamage can manifest as pigmentary disorders, particularly melasma and post-inflammatory hyperpigmentation (PIH), photoaging, photodermatoses, and skin cancer risk. Comprehensive photoprotection strategies for individuals with SOC include behavioral sun avoidance measures, sun-protective clothing, avoiding harmful behaviors, and community-based education programs. Sunscreen formulations for SOC should be tailored to skin phototype (SPT), with an SPF of 30 and broad protection that covers UVA, VL, and infrared A to limit hyperpigmentation and photoaging. Iron oxide-containing sunscreens provide VL protection and reduce white cast. Niacinamide-containing sunscreens are helpful for reducing PIH. Since UV and VL generate reactive oxygen species (ROS) that promote inflammation and persistent PIH, antioxidants in sunscreen are important in SOC to neutralize this damage and support DNA repair. Comprehensive photoprotection is essential for SOC populations. SOC individuals face unique manifestations of photodamage. Effective photoprotection in SOC requires extension beyond traditional UVB protection to meet the specific needs of SOC. Additionally, targeted education, community engagement, and barriers to care need to be addressed to improve outcomes. It is important for the dermatology community to commit to inclusivity and advocate for equitable access to photoprotection resources for all.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.